Soulbrain Co., Ltd. (357780.KQ)
Seongnam-si, KR
Headquartered in Seongnam-si, South Korea, Soulbrain Co., Ltd. specializes in the development, production, and distribution of essential advanced materials for various high-technology sectors. Their extensive product portfolio includes critical components for semiconductor manufacturing, such as CVD/ALD substances, specialized etching and cleaning agents (including hydrofluoric acid and buffered oxide etchants for silicon oxide films), chemical mechanical planarization (CMP) slurries, and plating solutions. The company is also a key supplier of functional chemical materials for liquid crystal display (LCD) and organic light-emitting diode (OLED) panels, encompassing elements for thin glass and cell scribing processes. Furthermore, Soulbrain contributes to green energy technologies with electronic materials for LED processing, solar cells, and electric vehicle applications. Diversifying its operations, Soulbrain also manufactures cosmetic products, notably hydrogel mask packs. It has a footprint in healthcare technology, offering electronic health record (EHR) and personal health record (PHR) platforms, alongside body concentration and drug-testing solutions. Additionally, the company provides a range of financial services, including funding for new technologies, M&A advisory, and operating a lending institution.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.17% | -11.15% | -26.57% | -30.28% | +26.78% | +21.33% | +100.65% | +46.54% | +2.58% | +29.20% | +29.20% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-06 | Change |
|---|---|---|
| Strong Buy | 5 | +1 |
| Buy | 7 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 1 | 0 |
-
Revenue growth Chemicals: +4.0%+7.0% ★ Q1'26: +25.9% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-32.8% Q1'26: +17.8% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+9.9% Q1'26: +7.0% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+14.4% ★ Q1'26: +16.9% (vs Q1'25)
-
ROIC Chemicals: +3.4%+11.0% ★ Q1'26: +15.0% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+0.5% Q1'26: -1.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×0.59× ★ Q1'26: 0.26× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 5 Rev. Ana. 13 EPS Ana. |
Dec 2027 14 Rev. Ana. 14 EPS Ana. |
Dec 2028 6 Rev. Ana. 7 EPS Ana. |
Dec 2029 9 Rev. Ana. 8 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
470.07B
est: 889.92B (-47.2%)
|
1.02T
est: 1.04T (-1.2%)
|
1.09T
est: 1.11T (-1.9%)
|
844.03B
est: 836.84B (+0.9%)
|
863.36B
est: 869.60B (-0.7%)
|
923.38B
est: 925.52B (-0.2%)
|
1.08T
1.07T – 1.09T
+16.7% YoY
|
1.24T
1.10T – 1.39T
+14.9% YoY
|
1.50T
1.41T – 1.61T
+21.0% YoY
|
1.28T
1.19T – 1.37T
-15.1% YoY
|
| EBITDA |
112.55B
est: 218.98B (-48.6%)
|
255.71B
est: 254.99B (+0.3%)
|
268.38B
est: 273.72B (-2.0%)
|
196.78B
est: 205.92B (-4.4%)
|
226.17B
est: 209.51B (+7.9%)
|
197.41B
est: 222.99B (-11.5%)
|
260.22B
257.62B – 263.60B
+16.7% YoY
|
299.09B
264.77B – 335.99B
+14.9% YoY
|
361.98B
338.53B – 387.60B
+21.0% YoY
|
307.19B
287.28B – 328.93B
-15.1% YoY
|
| EBIT |
88.47B
est: 167.90B (-47.3%)
|
207.13B
est: 195.51B (+5.9%)
|
215.74B
est: 209.87B (+2.8%)
|
136.25B
est: 157.89B (-13.7%)
|
167.20B
est: 156.30B (+7.0%)
|
132.52B
est: 166.35B (-20.3%)
|
194.12B
192.18B – 196.64B
+16.7% YoY
|
223.12B
197.52B – 250.65B
+14.9% YoY
|
270.04B
252.54B – 289.14B
+21.0% YoY
|
229.16B
214.31B – 245.38B
-15.1% YoY
|
| Net Income |
63.27B
est: 145.07B (-56.4%)
|
148.52B
est: 147.05B (+1.0%)
|
162.79B
est: 174.62B (-6.8%)
|
130.36B
est: 119.71B (+8.9%)
|
118.44B
est: 151.22B (-21.7%)
|
79.06B
est: 96.00B (-17.6%)
|
155.30B
131.66B – 176.58B
+61.8% YoY
|
194.11B
153.56B – 231.03B
+25.0% YoY
|
245.42B
224.74B – 267.99B
+26.4% YoY
|
212.95B
195.01B – 232.54B
-13.2% YoY
|
| SGA |
42.54B
est: 47.05B (-9.6%)
|
43.89B
est: 54.78B (-19.9%)
|
67.78B
est: 58.81B (+15.3%)
|
29.12B
est: 44.24B (-34.2%)
|
29.64B
est: 37.44B (-20.8%)
|
38.26B
est: 39.85B (-4.0%)
|
46.50B
46.03B – 47.10B
+16.7% YoY
|
53.44B
47.31B – 60.04B
+14.9% YoY
|
64.68B
60.49B – 69.26B
+21.0% YoY
|
54.89B
51.33B – 58.78B
-15.1% YoY
|
| EPS |
8,146.50
est: 18,735.74 (-56.5%)
|
19,123.00
est: 18,991.84 (+0.7%)
|
20,967.00
est: 22,552.19 (-7.0%)
|
16,832.00
est: 15,460.88 (+8.9%)
|
15,294.00
est: 19,439.05 (-21.3%)
|
10,284.00
est: 12,341.05 (-16.7%)
|
19,963.39
16,925.04 – 22,700.08
+61.8% YoY
|
24,953.12
19,740.34 – 29,699.66
+25.0% YoY
|
31,548.45
28,890.57 – 34,450.28
+26.4% YoY
|
27,375.00
25,068.72 – 29,892.95
-13.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-10 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-06-09 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-06-08 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-06-05 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-06-04 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-06-02 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-06-01 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-29 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-28 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-27 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-26 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-22 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-21 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-20 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-19 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-18 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-15 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-14 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-13 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-12 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-11 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-08 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-07 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-06 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-04 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-30 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-29 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-28 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Kodex Energy&Chemicals 117460.KS | 2.09% | 353.0K | 0.45% |
| 2 | Kodex KOSDAQ 150 229200.KS | 0.69% | 20.82M | 0.25% |
| 3 | SAMSUNG KODEX KOSDAQ150 LEVERAGE ETF 233740.KS | 0.21% | 4.71M | 0.64% |
| 4 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.10% | 121.1K | 0.42% |
| 5 | Kodex MSCI Quality 275300.KS | 0.09% | 34.7K | 0.30% |
| 6 | iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF ISFE.L | 0.07% | 53.1K | 0.74% |
| 7 | Kodex KRX300 292190.KS | 0.05% | 29.7K | 0.05% |
| 8 | iShares MSCI EM Small Cap UCITS ETF IEMS.L | 0.05% | 163.8K | 0.74% |
| 9 | iShares MSCI Emerging Markets Small-Cap ETF EEMS | 0.04% | 169.0K | 0.72% |
| 10 | State Street SPDR MSCI Emerging Markets Small Cap UCITS ETF EMSD.L | 0.04% | 245.0K | 0.55% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hwan Chul Rho | Chief Executive Officer & Director | — | — |
| Young-soo Park | Chairman & CEO | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 357780.KQ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
